http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-3070336-C

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d13d0316491db871a83ec74913e79ba4
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P23-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-245
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-245
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38
filingDate 2018-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2022-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f9810a11317a81a28a0fe2f63cb6a5e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fe7eea938147e2f64e188a308b37d59f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ddab1b7dfb3868d76a585ba5d671c382
publicationDate 2022-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-3070336-C
titleOfInvention Topical formulations of chloroprocaine and methods of using same
abstract Topical dosages and formulations of chloroprocaine, including gels and ointment, and methods of manufacturing and using same, are provided that are efficacious, chemically stable and physiologically balanced for safety and efficacy. The dosages and formulations are particularly useful during ophthalmic procedures or in response to ophthalmic abrasions or trauma based on their tolerability and pharmacokinetics.
priorityDate 2017-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID145932
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8759
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419493503
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4633
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24846132
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454515022
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426260513
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415850372
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID612
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419502648
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452860282
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68097
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474445
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID417109324
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534001
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID311
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4906
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451865412
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID441348
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490743
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408015872
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415739443
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID447315
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2337
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8612
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22304
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313

Total number of triples: 53.